Research indicates that mRNA vaccine-induced T cells respond robustly to new SARS-CoV-2 variants – News-Medical.Net

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, in late December 2019, more than 240 million recorded infections and over 4.89 million deaths have been attributed to this novel betacoronavirus. Globally,…

Click here to view the original article.